RAD-140 and Winstrol Interaction

Avoid
Mechanism-based 53% confidence

RAD-140 and Winstrol have a potentially harmful interaction with 53% confidence. Both RAD-140 and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the gonads and liver and heart, so monitoring these systems is recommended.

Compound Profiles

RAD-140

Selective Androgen Receptor Modulator | Investigational SARM

RAD-140 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a full agonist in muscle and bone tissue while exhibiting minimal agonist activity in the prostate and other androgen-sensitive tissues. This tissue selectivity is achieved through differential cofactor recruitment: upon binding to the AR, RAD-140 induces a conformational change that favors interaction with coactivators predominantly expressed in skeletal muscle and bone, rather than those prevalent in prostate or sebaceous glands.

Half-life: ~60 hours Typical dose: 10-20 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskcrosses bbb
View full profile

Winstrol

DHT-Derived Anabolic Steroid | Cutting & Athletic Performance

Stanozolol exerts its effects through binding to the intracellular androgen receptor (AR), promoting nitrogen retention, protein synthesis, and red blood cell production. As a DHT derivative, it cannot be aromatized by the aromatase enzyme, eliminating estrogen-mediated side effects.

Half-life: ~9 hours (oral), ~24 hours (injectable) Typical dose: 25-50 mg/day (oral), 50 mg EOD (injectable) anabolic
androgen receptoraromataseepo receptorshbg androgenicblood pressure raisingcarcinogenic riskcardiotoxic
View full profile

Combined Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate

Shared Safety Flags

2x 2 androgenic compounds (RAD-140, Winstrol). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds raise blood pressure (RAD-140, Winstrol). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the carcinogenic-risk safety flag (RAD-140, Winstrol). Monitor accordingly.
2x 2 hepatotoxic compounds (RAD-140, Winstrol). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (RAD-140, Winstrol). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (RAD-140, Winstrol). Get lipid panel mid-cycle — consider adding lipid support.

Frequently Asked Questions

Can I take RAD-140 with Winstrol?

Combining RAD-140 with Winstrol is not recommended. Both RAD-140 and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is RAD-140 and Winstrol safe together?

This combination carries significant risk. Both RAD-140 and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between RAD-140 and Winstrol?

Both RAD-140 and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 53% confidence and is inferred from pharmacological mechanism analysis.

How should I time RAD-140 and Winstrol?

RAD-140 has a half-life of ~60 hours and Winstrol has a half-life of ~9 hours (oral), ~24 hours (injectable). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: RAD-140 vs Winstrol

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.